Moreover, CD69 controls T-cell differentiation through its interaction with galectin-148, and TGF-β-triggered CXCL12/CXCR4 signaling has been demonstrated to promote tumor invasion, metastasis, and therapeutic resistance49. The gene discussed is CD69; the disease is neoplasm.